Request Deal Involvement
US WorldMeds completed the acquisition of Tecelra from Adaptimmune Therapeutics for $85m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
TD Cowen
legal advisors to financial advisors
White & Case
legal advisors
Ropes & Gray
legal advisors
Gibson Dunn & Crutcher
or
Principals
vendor
ADAPTIMMUNE THERAPEUTICS PLC
bidder
US WORLDMEDS
target
TECELRA
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite